Zobrazeno 1 - 10
of 53
pro vyhledávání: '"Yong Mei, Yin"'
Publikováno v:
Gynecologic Oncology Reports, Vol 45, Iss , Pp 101142- (2023)
Patients with human immunodeficiency virus (HIV) are at increased risk for developing other gynecologic conditions, including herpes simplex virus (HSV) and vulvar intraepithelial neoplasia (VIN)/carcinoma. We describe the case of a woman with a hist
Externí odkaz:
https://doaj.org/article/f61a4ac882ea40e5acfe7ae72f109957
Autor:
Jin-Hu Fan, Su Zhang, Huan Yang, Zong-Bi Yi, Qu-Chang Ouyang, Min Yan, Xiao-Jia Wang, Xi-Chun Hu, Ze-Fei Jiang, Tao Huang, Zhong-Sheng Tong, Shu-Sen Wang, Yong-Mei Yin, Hui Li, Run-Xiang Yang, Hua-Wei Yang, Yue-E. Teng, Tao Sun, Li Cai, Hong-Yuan Li, Xue-Nong Ouyang, Jian-Jun He, Xin-Lan Liu, Shun-E. Yang, Jia-Yu Wang, Bing-He Xu, You-Lin Qiao
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
ObjectiveThis study aimed to explore possible associations between molecular subtypes and site of distant metastasis in advanced breast cancer (ABC).Methods3577 ABC patients were selected from 21 hospitals of seven geographic regions in China from 20
Externí odkaz:
https://doaj.org/article/d59fc4f00f5042a8a6ce6d73845e9301
Autor:
Qing Yuan Zhang, Tao Sun, Yong Mei Yin, Hui Ping Li, Min Yan, Zhong Sheng Tong, Christina P. Oppermann, Yun Peng Liu, Romulo Costa, Man Li, Ying Cheng, Qu Chang Ouyang, Xi Chen, Ning Liao, Xin Hong Wu, Xiao Jia Wang, Ji Feng Feng, Roberto Hegg, G.B. Kanakasetty, Maria A. Coccia-Portugal, Ru Bing Han, Yi Lu, Hai Dong Chi, Ze Fei Jiang, Xi Chun Hu
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 12 (2020)
Aim: To compare the efficacy, safety, and tolerability of abemaciclib plus endocrine therapy (ET) versus ET alone in postmenopausal women with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced breast ca
Externí odkaz:
https://doaj.org/article/97a1aeef27ca442790bae5374547f9e7
Autor:
Xiao-Jia Wang, Jian Huang, Xi-ying Shao, Li Cai, Yong-mei Yin, Li-li Zhang, Peng Shen, Yan-xia Shi
Publikováno v:
Cancer Research. 82:P1-17
Background: OVERSTEP is a multicenter, randomized clinical trial of capecitabine (CAP) versus endocrine therapy (HT) as maintenance therapy after 1st-line CAP-based combination chemotherapy in HR+/HER2- ABC/MBC. At 2020 SABCS conference, we have repo
Autor:
José, Jessurun, Christine, Orr, Samantha N, McNulty, Catherine E, Hagen, Hussein, Alnajar, David, Wilkes, Sarah, Kudman, Majd, Al Assaad, Princesca, Dorsaint, Kentaro, Ohara, Feng, He, Kenrry, Chu, Yong Mei, Yin, Jenny Zhaoying, Xiang, Lihui, Qin, Andrea, Sboner, Olivier, Elemento, Rhonda K, Yantiss, Rondell P, Graham, Flora, Poizat, Juan Miguel, Mosquera
Publikováno v:
American Journal of Surgical Pathology. 47:65-73
GLI1 encodes a transcription factor that targets cell cycle regulators affecting stem cell proliferation. GLI1 gene fusions were initially described in pericytomas with a t[7;12] translocation and more recently in gastric plexiform fibromyxomas and g
Publikováno v:
Pharmaceutics, Vol 12, Iss 9, p 783 (2020)
Cholesteryl hemisuccinate (CHS)-conjugated chitosan (CS)-based self-assembled nanoparticles (NPs) were developed for enhancing the intracellular uptake of docetaxel in multidrug resistance (MDR)-acquired cancer cells. CHS-CS was successfully synthesi
Externí odkaz:
https://doaj.org/article/dd6f14f7eea24ff39bcfb387d2a81264
Publikováno v:
Annals of translational medicine. 10(16)
Triple negative breast cancer (TNBC) refers to a special subtype of breast cancer that is negative for the estrogen receptor, the progesterone receptors, and human epidermal growth factor receptor 2. As a group of diseases, it has strong heterogeneit
Autor:
Huan Yang, Qu-Chang Ouyang, Min Yan, Xiao-Jia Wang, Xi-Chun Hu, Ze-Fei Jiang, Tao Huang, Zhong-Sheng Tong, Shu-Sen Wang, Yong-Mei Yin, Hui Li, Run-Xiang Yang, Hua-Wei Yang, Yue-E Teng, Tao Sun, Li Cai, Hong-Yuan Li, Xue-Nong Ouyang, Jian-Jun He, Xin-Lan Liu, Shun-E Yang, Jin-Hu Fan, Jia-Yu Wang, You-Lin Qiao, Bing-He Xu
Publikováno v:
Annals of translational medicine. 10(15)
Several studies have indicated possible associations between age and the prognosis of breast cancer (BC), but limited data are available from hospital-based multicenter studies in China. This study aimed to explore the associations between age at ini
Autor:
Xin Hong Wu, Hai Dong Chi, Ying Cheng, Min Yan, Zhong Sheng Tong, Hui Ping Li, Ze Fei Jiang, Yi Lu, Man Li, Xi Chen, Tao Sun, Qu Chang Ouyang, Ning Liao, G.B. Kanakasetty, Yong Mei Yin, Yunpeng Liu, Xi Chun Hu, Roberto Hegg, Xiao Jia Wang, Ru Bing Han, Ji Feng Feng, Maria A. Coccia-Portugal, Romulo Costa, Christina Pimentel Oppermann, Q. Zhang
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 12 (2020)
Therapeutic Advances in Medical Oncology
Therapeutic Advances in Medical Oncology
Aim:To compare the efficacy, safety, and tolerability of abemaciclib plus endocrine therapy (ET) versus ET alone in postmenopausal women with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced breast can
Esophageal cancer (ESCC) is one of the most common causes of cancer-associated mortality in China. The present investigation reveals that non-coding RNAs (ncRNAs), including long ncRNAs (lncRNAs), exert a significant effect on the initiation, develop
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8fe2c3cf0e89c332f5489ffb0a1aa071
https://europepmc.org/articles/PMC5876463/
https://europepmc.org/articles/PMC5876463/